Geneos Wealth Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $566 | Sell |
29
-48
| -62% | -$952 | ﹤0.01% | 2467 |
|
|
2026
Q1 | $1.48K | Hold |
77
| – | – | ﹤0.01% | 2355 |
|
|
2025
Q4 | $1.46K | Hold |
77
| – | – | ﹤0.01% | 2364 |
|
|
2025
Q3 | $1.44K | Hold |
77
| – | – | ﹤0.01% | 2366 |
|
|
2025
Q2 | $1.42K | Hold |
77
| – | – | ﹤0.01% | 2896 |
|
|
2025
Q1 | $1.34K | Hold |
77
| – | – | ﹤0.01% | 2869 |
|
|
2024
Q4 | $1.33K | Hold |
77
| – | – | ﹤0.01% | 2708 |
|
|
2024
Q3 | $1.43K | Hold |
77
| – | – | ﹤0.01% | 2371 |
|
|
2024
Q2 | $1.19K | Sell |
77
-166
| -68% | -$2.37K | ﹤0.01% | 1961 |
|
|
2024
Q1 | $3.59K | Hold |
243
| – | – | ﹤0.01% | 1780 |
|
|
2023
Q4 | $3.47K | Buy |
243
+29
| +14% | +$412 | ﹤0.01% | 1811 |
|
|
2023
Q3 | $2.98K | Hold |
214
| – | – | ﹤0.01% | 1865 |
|
|
2023
Q2 | $2.52K | Hold |
214
| – | – | ﹤0.01% | 1892 |
|
|
2023
Q1 | $2.46K | Hold |
214
| – | – | ﹤0.01% | 1871 |
|
|
2022
Q4 | $2.66K | Sell |
214
-3,250
| -94% | -$41.4K | ﹤0.01% | 1838 |
|
|
2022
Q3 | $45K | Sell |
3,464
-2,181
| -39% | -$32.2K | ﹤0.01% | 1065 |
|
|
2022
Q2 | $80K | Buy |
5,645
+3,952
| +233% | +$52.8K | ﹤0.01% | 1098 |
|
|
2022
Q1 | $25K | Sell |
1,693
-3,641
| -68% | -$49.8K | ﹤0.01% | 1695 |
|
|
2021
Q4 | $72K | Buy |
5,334
+3
| +0.1% | +$42 | ﹤0.01% | 1311 |
|
|
2021
Q3 | $79K | Sell |
5,331
-23
| -0.4% | -$389 | ﹤0.01% | 1264 |
|
|
2021
Q2 | $97K | Sell |
5,354
-124
| -2% | -$2.21K | ﹤0.01% | 1173 |
|
|
2021
Q1 | $99K | Hold |
5,478
| – | – | ﹤0.01% | 1316 |
|
|
2020
Q4 | $93K | Buy |
5,478
+3,366
| +159% | +$53.7K | ﹤0.01% | 1181 |
|
|
2020
Q3 | $29K | Buy |
2,112
+2
| +0.1% | +$29 | ﹤0.01% | 1487 |
|
|
2020
Q2 | $29K | Sell |
2,110
-351
| -14% | -$4.61K | ﹤0.01% | 1459 |
|
|
2020
Q1 | $27K | Sell |
2,461
-48
| -2% | -$885 | ﹤0.01% | 1391 |
|
|
2019
Q4 | $52K | Sell |
2,509
-566
| -18% | -$12.7K | ﹤0.01% | 1231 |
|
|
2019
Q3 | $70K | Buy |
3,075
+571
| +23% | +$12.2K | ﹤0.01% | 1029 |
|
|
2019
Q2 | $49K | Sell |
2,504
-155
| -6% | -$3.02K | ﹤0.01% | 1201 |
|
|
2019
Q1 | $51K | Sell |
2,659
-50
| -2% | -$947 | ﹤0.01% | 1131 |
|
|
2018
Q4 | $44K | Buy |
2,709
+3
| +0.1% | +$60 | ﹤0.01% | 1157 |
|
|
2018
Q3 | $62K | Buy |
2,706
+168
| +7% | +$3.81K | ﹤0.01% | 1073 |
|
|
2018
Q2 | $55K | Sell |
2,538
-229
| -8% | -$4.47K | ﹤0.01% | 1002 |
|
|
2018
Q1 | $48K | Sell |
2,767
-431
| -13% | -$7.6K | ﹤0.01% | 1010 |
|
|
2017
Q4 | $60K | Sell |
3,198
-160
| -5% | -$3.18K | 0.01% | 927 |
|
|
2017
Q3 | $73K | Buy |
3,358
+3,192
| +1,923% | +$72.1K | 0.01% | 812 |
|
|
2017
Q2 | $4K | Hold |
166
| – | – | ﹤0.01% | 1807 |
|
|
2017
Q1 | $4K | Hold |
166
| – | – | ﹤0.01% | 1752 |
|
|
2016
Q4 | $4K | Hold |
166
| – | – | ﹤0.01% | 1704 |
|
|
2016
Q3 | $4K | Hold |
166
| – | – | ﹤0.01% | 1644 |
|
|
2016
Q2 | $3K | Sell |
166
-140
| -46% | -$2.92K | ﹤0.01% | 1630 |
|
|
2016
Q1 | $6K | Buy |
+306
| New | +$5.87K | ﹤0.01% | 1451 |
|
Other funds holding SBRA
CIM
Geneos Wealth Management's SBRA Position: Q2 2026 in Review
Geneos Wealth Management reduced its Sabra Healthcare REIT (SBRA) stake by 62% in Q2 2026, selling an estimated $952 and leaving 29 shares worth $566. The position accounts for ﹤0.01% of the portfolio, ranked #2467.
Geneos Wealth Management first reported a position in SBRA in Q1 2016 and has held it in 42 quarters since. The position peaked at $99K in Q1 2021. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Geneos Wealth Management held 29 shares of Sabra Healthcare REIT worth $566 as of Q2 2026.
- Geneos Wealth Management sold 48 Sabra Healthcare REIT shares in Q2 2026, an estimated $952.
- Sabra Healthcare REIT made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2467 holding.
- Geneos Wealth Management first reported a position in Sabra Healthcare REIT in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's Sabra Healthcare REIT position peaked at $99K in Q1 2021.
- 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.